{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:44:48Z","timestamp":1792097088862,"version":"4.4.0"},"reference-count":24,"publisher":"Massachusetts Medical Society","issue":"12","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2020,3,19]]},"DOI":"10.1056\/nejmoa1909512","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T17:05:35Z","timestamp":1583341535000},"page":"1124-1135","source":"Crossref","is-referenced-by-count":474,"title":["Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection"],"prefix":"10.1056","volume":"382","author":[{"given":"Chloe","family":"Orkin","sequence":"first","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keikawus","family":"Arasteh","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"G\u00f3rgolas Hern\u00e1ndez-Mora","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Pokrovsky","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar T.","family":"Overton","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Girard","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Walmsley","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1148-6985","authenticated-orcid":false,"given":"Chris","family":"Bettacchi","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Brinson","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Philibert","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lombaard","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marty","family":"St. Clair","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herta","family":"Crauwels","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Ford","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Patel","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Chounta","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Vanveggel","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dorey","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cutrell","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Griffith","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Margolis","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Williams","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Parys","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly Y.","family":"Smith","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Spreen","sequence":"additional","affiliation":[{"name":"From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) \u2014 both in the United Kingdom; EPIMED, Berlin (K.A.); Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); H\u00f4pital Saint Antoine, Paris (P.-M.G.), and H\u00f4pital Europ\u00e9en, Marseille (P. Philibert) \u2014 both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/505147"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013911"},{"key":"e_1_3_5_4_2","first-page":"w14016","article-title":"Asking about adherence \u2014 from flipping the coin to strong evidence.","volume":"144","author":"Glass T","year":"2014","unstructured":"Glass T, Cavassini M. Asking about adherence \u2014 from flipping the coin to strong evidence. Swiss Med Wkly 2014;144:w14016-w14016.25275364","journal-title":"Swiss Med Wkly"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-011-9942-x"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.12.214"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001896"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32462-0"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33095-7"},{"key":"e_1_3_5_10_2","unstructured":"Odefsey prescribing information. Foster City CA: Gilead Sciences 2018 (https:\/\/www.gilead.com\/~\/media\/files\/pdfs\/medicines\/hiv\/odefsey\/odefsey_pi.pdf?la=en)."},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000469"},{"key":"e_1_3_5_12_2","unstructured":"Edurant (rilpivirine) prescribing information. Titusville NJ: Janssen Therapeutics 2019 (http:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/EDURANT-pi.pdf)."},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31917-7"},{"key":"e_1_3_5_14_2","unstructured":"Margolis DA Gonzalez Garcia J Stellbrink HJ et al. Safety efficacy and durability of long-acting cabotegravir (CAB) and rilpivirine (RPV) as two-drug IM maintenance therapy for HIV-1 infection: LATTE-2 week 160 results. Presented at HIV Glasgow 2018 Glasgow Scotland October 28\u201331 2018."},{"key":"e_1_3_5_15_2","unstructured":"FDA Center for Drug Evaluation and Research. Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment. Guidance for industry. November 2015 (https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm355128.pdf)."},{"key":"e_1_3_5_16_2","unstructured":"National Institutes of Health. Division of AIDS table for grading the severity of adult and pediatric adverse events version 1.0. 2009 (https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/table-for-grading-severity-of-adult-pediatric-adverse-events.pdf)."},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30647-9"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013050904635"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904398"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","unstructured":"Crauwels HM van Schaick E Van Heeswijk RP Vanveggel S Boven K Vis P. Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral-naive HIV-1-infected patients in ECHO and THRIVE. Presented at the 10th International Congress on Drug Therapy in HIV Infection. Glasgow Scotland November 7\u201311 2010.","DOI":"10.1186\/1758-2652-13-S4-P186"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00152-8"},{"key":"e_1_3_5_22_2","first-page":"132","article-title":"2017 Update of the drug resistance mutations in HIV-1.","volume":"24","author":"Wensing AM","year":"2016","unstructured":"Wensing AM, Calvez V, G\u00fcnthard HF, et al. 2017 Update of the drug resistance mutations in HIV-1. Top Antivir Med 2016;24:132-133.28208121","journal-title":"Top Antivir Med"},{"key":"e_1_3_5_23_2","unstructured":"Stanford University HIV Drug Resistance Database. 2019 (https:\/\/hivdb.stanford.edu\/)."},{"key":"e_1_3_5_24_2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Washington DC: Department of Health and Human Services 2019 (http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf.)"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-13-138"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1909512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:39:58Z","timestamp":1711485598000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1909512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,3,19]]}},"alternative-id":["10.1056\/NEJMoa1909512"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1909512","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]}}}